BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 23, 2026
See today's BioWorld MedTech
Home
» China ripe with opportunity: Ativa Medical brings in $15M in Series B equity funding
To read the full story,
subscribe
or
sign in
.
China ripe with opportunity: Ativa Medical brings in $15M in Series B equity funding
Sep. 18, 2015
By
Omar Ford
The emerging health care market in China has been a significant driver in Ativa Medical (St. Paul, Minn.) closing its Series B funding round.
Medical technology
